Literature DB >> 3963187

Regulation of interorganal glutamine flow in metabolic acidosis.

T C Welbourne, V Phromphetcharat, G Givens, S Joshi.   

Abstract

Metabolic acidosis redirects interorgan glutamine flow from hepatic utilization to renal ammoniagenesis at the expense of ureagenesis. The roles of arterial glutamine load and organ glutaminase capacity in the regulation of glutamine balance across the gut, liver, and kidneys were studied in control and chronically acidotic rats. In control rats these organs combined to remove 733 nmol glutamine X min-1 X 100 g-1 in agreement with their respective glutaminase content, gut greater than liver greater than kidneys. In chronic metabolic acidosis renal glutamine extraction alone increased to 1,158 nmol X min-1 X 100 g-1 associated with an increased glutaminase capacity. However, the total glutamine deficit across these organs rose to only 1,043 nmol glutamine consumed X min-1 X 100 g-1 as a consequence of hepatic glutamine uptake reversing to net release. This reversal was not dependent on increased hepatic glutamine synthetase capacity, but rather appears to be dependent on the combined effect of reduced portal venous glutamine load and increased ammonia load. The reduction in portal glutamine load is, in turn, a consequence of renal glutamine extraction and reduced arterial glutamine concentration in metabolic acidosis as well as maintained gut glutamine extraction. Elevating arterial glutamine concentration in metabolic acidosis has no effect on renal uptake, but enhances splanchnic bed extraction with the restoration of ureagenesis. Thus the interorgan flow of glutamine and deposition of N into either urea or ammonia appears to be dependent on arterial glutamine concentration and hence glutamine availability in chronic metabolic acidosis in the rat.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3963187     DOI: 10.1152/ajpendo.1986.250.4.E457

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

Review 1.  The emerging role of glutamine as an indicator of exercise stress and overtraining.

Authors:  D G Rowbottom; D Keast; A R Morton
Journal:  Sports Med       Date:  1996-02       Impact factor: 11.136

2.  Glutamine gluconeogenesis in the small intestine of 72 h-fasted adult rats is undetectable.

Authors:  Guy Martin; Bernard Ferrier; Agnès Conjard; Mireille Martin; Rémi Nazaret; Michelle Boghossian; Fadi Saadé; Claire Mancuso; Daniel Durozard; Gabriel Baverel
Journal:  Biochem J       Date:  2007-01-15       Impact factor: 3.857

3.  Influence of progressive tumor growth on glutamine metabolism in skeletal muscle and kidney.

Authors:  M K Chen; N J Espat; K I Bland; E M Copeland; W W Souba
Journal:  Ann Surg       Date:  1993-06       Impact factor: 12.969

4.  Effects of methionine sulphoximine treatment on renal amino acid and ammonia metabolism in rats.

Authors:  S Heeneman; C H Dejong; N E Deutz
Journal:  Pflugers Arch       Date:  1994-07       Impact factor: 3.657

5.  Chronic binge ethanol-mediated acidemia reduces availability of glutamine and related amino acids in maternal plasma of pregnant sheep.

Authors:  Jayanth Ramadoss; Guoyao Wu; Timothy A Cudd
Journal:  Alcohol       Date:  2008-12       Impact factor: 2.405

6.  Creatine synthesis: hepatic metabolism of guanidinoacetate and creatine in the rat in vitro and in vivo.

Authors:  Robin P da Silva; Itzhak Nissim; Margaret E Brosnan; John T Brosnan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-11-18       Impact factor: 4.310

7.  Gamma glutamyltransferase contribution to renal ammoniagenesis in vivo.

Authors:  T C Welbourne; P D Dass
Journal:  Pflugers Arch       Date:  1988-05       Impact factor: 3.657

Review 8.  Interorgan ammonia trafficking in liver disease.

Authors:  Steven W M Olde Damink; Rajiv Jalan; Cornelius H C Dejong
Journal:  Metab Brain Dis       Date:  2008-12-09       Impact factor: 3.584

9.  Renal ammonia and glutamine metabolism during liver insufficiency-induced hyperammonemia in the rat.

Authors:  C H Dejong; N E Deutz; P B Soeters
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.